Return to homepagePandemic Pact

National and targeted sero-surveys of population immunity to SARS-COV2 to inform clinical and public health responses

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    -99

  • Known Financial Commitments (USD)

    $87,310.11

  • Funder

    APPRISE

  • Principal Investigator

    Kristine Macartney &Kaldor, John

  • Research Location

    Australia

  • Lead Research Institution

    National Centre for Immunisation Research and Surveillance, NCIRS and Kirby Institute

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

National and targeted sero-surveys of population immunity to SARS-COV2 to inform clinical and public health responsesObjectives:Determine the prevalence of SARS-CoV-2 infection at a national level during and following the initial wave of community transmissionDetermine the prevalence of SARS-CoV-2 infection in vulnerable populationsDetermine factors (demographic, individual-level, occupational, travel or other) associated with the development of SARS-CoV-2 infection at a national and subpopulation levelExamine the utility of newly developed serological assays for the detection of SARS-CoV-2 infection